$AYI

GOLDMAN BARRY R sold $439K of AYI

GOLDMAN BARRY R (SVP & General Counsel) sold 1,200 shares of ACUITY INC. (DE) (AYI) at $365.65 ($0.44M total) on 2026-07-02.

Original reporting
SEC EDGAR · GOLDMAN BARRY R
Published Jul 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:55 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AYI
Neutral
low confidence
Mentioned
$AYI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AYINeutralLow
01

Why it matters

The filing discloses an open-market sale by the SVP and General Counsel, but provides no new guidance, earnings, contracts, or regulatory developments.

02

Market read

Traders may note the insider sale for sentiment, but it is unlikely to change valuation absent other company-specific news.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without context on prior plans or compensation, signal quality is low.

Relevance 4/10Novelty 2/10Timing: Form 4 filed 2026-07-06, covering a sale executed 2026-07-02.

Background

The article is an SEC Form 4 insider transaction disclosure for Acuity Brands (AYI).

Company-level read

Ticker impact

$AYINeutralLow confidence
Context

Acuity Brands insider Goldman Barry R sold 1,200 shares at $365.65 on 2026-07-02, per a Form 4 filed 2026-07-06.

Expected impact

Likely minimal near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

Form 4 insider sales are common and this filing provides no new company-specific operational or financial information, only transaction details.

Market effects

No clear sector read-through from a single insider sale without accompanying company news.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as less “mechanical” selling, but the article still lacks any corroborating fundamental catalyst.

Key entities

  • ACUITY INC. (DE)

    Company whose insider transaction is disclosed on Form 4.

  • GOLDMAN BARRY R

    SVP and General Counsel who sold 1,200 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNHighAI 8/10

Company News for Oct 2, 2026

Accenture's (ACN) shares rose 15.8% after beating Q4 earnings estimates. Acuity (AYI) fell 3.4% missing revenue estimates. McKesson (MCK) gained 5.3% after reaffirming fiscal 2027 EPS guidance. Progress Software (PRGS) dropped 8.5% after missing Q3 revenue estimates.

$AYIMedAI 8/10

AYI Q3 Deep Dive: Margin Expansion Outpaces Revenue Growth Amid Mixed Top-Line Results

Acuity Brands (AYI) reported Q3 revenue of $1.24B, up 2.9% YoY, missing estimates but exceeding EPS expectations with $5.77 per share. Management highlighted margin expansion in lighting and growth in Intelligent Spaces, offset by softer lighting market performance. Future challenges include higher memory costs, while opportunities lie in new verticals and innovation.

$AYIMedAI 8/10

Acuity (AYI) Stock Slips As AIS Gains Meet Memory Cost Pressure

Acuity (AYI) stock fell 3.4% to $299.28, despite Q4 revenue growth of 2.9% and EPS increase of 55.4%. Acuity Intelligent Spaces (AIS) grew to 25% of revenue, boosting margins. However, memory cost pressures and flat ABL sales raised concerns. Net income rose 51.8% to $173.0M, with net profit margin improving to 11.4%.

$AYIHighAI 8/10

Acuity (AYI) Q4 2026 Earnings Call Transcript

Acuity Brands (AYI) reported Q4 2026 net sales of $4.6B, up 6.8% YoY, driven by its intelligent spaces portfolio. Adjusted EPS rose 11% to $5.77, while gross margin expanded 130 bps to 50.2%. The lighting segment saw a 0.4% sales decline, while intelligent spaces grew 16.6%. Fiscal 2027 guidance: $4.7B-$4.9B revenue, $20.50-$22.00 EPS. The company repurchased $287M in shares and fully repaid QSC acquisition debt.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.